Pharmacotherapeutics for Advanced Practice
Nurse Prescribers with Davis Edge
6th Edition
1.
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: A newly licensed Family Nurse Practitioner
(FNP) is preparing to join a primary care practice. To determine
the specific drugs and devices they are legally authorized to
prescribe, the FNP should first review which of the following?
Options:
A) The practice's collaborative agreement with a supervising
physician.
B) The American Nurses Association (ANA) Code of Ethics for
Nurses.
C) The state's Nurse Practice Act and regulations for APRNs.
D) The formulary of the major insurance providers in the region.
Correct Answer: C
Rationales:
• Correct: The authority to prescribe, including the scope of
prescriptive authority (which drugs/devices), is defined
and regulated by each state's Nurse Practice Act and its
associated rules and regulations for APRNs.
, • Incorrect A: While a collaborative agreement may be
required by the state and can outline procedures, the
foundational legal authority originates from the state's
Nurse Practice Act.
• Incorrect B: The ANA Code of Ethics provides guidance on
ethical conduct but does not confer legal prescriptive
authority.
• Incorrect D: An insurance formulary determines coverage
and reimbursement, not the legal authority to prescribe a
medication.
Teaching Point: Prescriptive authority is granted and
defined by state law, not institutional policy.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis Company.
Ch. 1, The Advanced Practice Registered Nurse (APRN) as
Prescriber.
2.
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: An APRN is licensed in a state that requires a
collaborative agreement with a physician for prescriptive
authority. The primary purpose of this agreement, from a
regulatory standpoint, is to ensure:
Options:
A) The physician reviews every prescription written by the APRN
,before it is dispensed.
B) A structured process for consultation, referral, and
collaboration exists for complex patient cases.
C) The APRN's prescribing patterns are identical to the
collaborating physician's patterns.
D) The physician assumes full liability for all prescribing
decisions made by the APRN.
Correct Answer: B
Rationales:
• Correct: Collaborative agreements are designed to
formalize a relationship that ensures patient access to
consultation and referral when a patient's needs exceed
the APRN's scope of practice or expertise, thereby
enhancing patient safety.
• Incorrect A: The agreement does not typically require pre-
approval of every prescription; this would undermine the
APRN's independent clinical judgment and efficiency.
• Incorrect C: APRNs are expected to exercise their own
independent judgment based on their education and
certification, not to mirror a physician's practice.
• Incorrect D: Liability is not transferred; the APRN maintains
responsibility for their own prescribing actions.
Teaching Point: Collaboration ensures a safety net for
consultation, not control over independent practice.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
, Prescribers with Davis Edge (6th ed.). F.A. Davis Company.
Ch. 1, The Advanced Practice Registered Nurse (APRN) as
Prescriber.
3.
Reference: Ch. 1, Section: The Role of the APRN Prescriber
Question Stem: When considering a new medication for a
patient, an APRN utilizes a framework that includes assessing
the patient's diagnosis, comorbidities, and current medications.
This process best demonstrates the APRN's role in:
Options:
A) Pharmacokinetic monitoring.
B) Therapeutic decision-making.
C) Patient education.
D) Cost-effective analysis.
Correct Answer: B
Rationales:
• Correct: Therapeutic decision-making is the core process
of selecting the most appropriate drug therapy based on a
comprehensive patient assessment, including diagnosis,
patient-specific factors, and evidence-based guidelines.
• Incorrect A: Pharmacokinetic monitoring is a component
of this process but describes the specific action of
monitoring drug levels, not the overarching decision-
making framework.
• Incorrect C: Patient education is a critical step that occurs
after a therapeutic decision has been made.
Nurse Prescribers with Davis Edge
6th Edition
1.
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: A newly licensed Family Nurse Practitioner
(FNP) is preparing to join a primary care practice. To determine
the specific drugs and devices they are legally authorized to
prescribe, the FNP should first review which of the following?
Options:
A) The practice's collaborative agreement with a supervising
physician.
B) The American Nurses Association (ANA) Code of Ethics for
Nurses.
C) The state's Nurse Practice Act and regulations for APRNs.
D) The formulary of the major insurance providers in the region.
Correct Answer: C
Rationales:
• Correct: The authority to prescribe, including the scope of
prescriptive authority (which drugs/devices), is defined
and regulated by each state's Nurse Practice Act and its
associated rules and regulations for APRNs.
, • Incorrect A: While a collaborative agreement may be
required by the state and can outline procedures, the
foundational legal authority originates from the state's
Nurse Practice Act.
• Incorrect B: The ANA Code of Ethics provides guidance on
ethical conduct but does not confer legal prescriptive
authority.
• Incorrect D: An insurance formulary determines coverage
and reimbursement, not the legal authority to prescribe a
medication.
Teaching Point: Prescriptive authority is granted and
defined by state law, not institutional policy.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis Company.
Ch. 1, The Advanced Practice Registered Nurse (APRN) as
Prescriber.
2.
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: An APRN is licensed in a state that requires a
collaborative agreement with a physician for prescriptive
authority. The primary purpose of this agreement, from a
regulatory standpoint, is to ensure:
Options:
A) The physician reviews every prescription written by the APRN
,before it is dispensed.
B) A structured process for consultation, referral, and
collaboration exists for complex patient cases.
C) The APRN's prescribing patterns are identical to the
collaborating physician's patterns.
D) The physician assumes full liability for all prescribing
decisions made by the APRN.
Correct Answer: B
Rationales:
• Correct: Collaborative agreements are designed to
formalize a relationship that ensures patient access to
consultation and referral when a patient's needs exceed
the APRN's scope of practice or expertise, thereby
enhancing patient safety.
• Incorrect A: The agreement does not typically require pre-
approval of every prescription; this would undermine the
APRN's independent clinical judgment and efficiency.
• Incorrect C: APRNs are expected to exercise their own
independent judgment based on their education and
certification, not to mirror a physician's practice.
• Incorrect D: Liability is not transferred; the APRN maintains
responsibility for their own prescribing actions.
Teaching Point: Collaboration ensures a safety net for
consultation, not control over independent practice.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
, Prescribers with Davis Edge (6th ed.). F.A. Davis Company.
Ch. 1, The Advanced Practice Registered Nurse (APRN) as
Prescriber.
3.
Reference: Ch. 1, Section: The Role of the APRN Prescriber
Question Stem: When considering a new medication for a
patient, an APRN utilizes a framework that includes assessing
the patient's diagnosis, comorbidities, and current medications.
This process best demonstrates the APRN's role in:
Options:
A) Pharmacokinetic monitoring.
B) Therapeutic decision-making.
C) Patient education.
D) Cost-effective analysis.
Correct Answer: B
Rationales:
• Correct: Therapeutic decision-making is the core process
of selecting the most appropriate drug therapy based on a
comprehensive patient assessment, including diagnosis,
patient-specific factors, and evidence-based guidelines.
• Incorrect A: Pharmacokinetic monitoring is a component
of this process but describes the specific action of
monitoring drug levels, not the overarching decision-
making framework.
• Incorrect C: Patient education is a critical step that occurs
after a therapeutic decision has been made.
